|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.75 USD | +4.81% |
|
-.--% | +1.78% |
| 06-01 | Orion reports positive Phase 1 cancer data | FW |
| 06-01 | Orion's Solid Tumours Treatment Shows Early Efficacy, Favorable Safety Profile in Phase 1/2 Trial | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ORNBV Stock
- ORINF Stock
- Consensus Orion Oyj
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
